SGLT-2 inhibitors and dementia
- PMID: 39197937
- DOI: 10.1136/bmj.q1841
SGLT-2 inhibitors and dementia
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: None. Further details of The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
Comment on
-
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.BMJ. 2024 Aug 28;386:e079475. doi: 10.1136/bmj-2024-079475. BMJ. 2024. PMID: 39197881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical